文献速递气道管理小儿麻醉

经鼻湿化快速充气通气交换可改善幼年型复发性呼吸道乳头状瘤病患儿的术中氧合

Transnasal Humidified Rapid Insufflation Ventilatory Exchange Augments Oxygenation in Children With Juvenile Onset Recurrent Respiratory Papillomatosis During Surgery: A Prospective Randomized Crossover Controlled Trial.
PubMed 文献 · Anesth Analg · 2023-05-19

结果显示THRIVE组呼吸暂停时间显著延长(8.9 vs 3.8分钟),二氧化碳上升速率降低,最低SpO2更高,提示THRIVE可安全用于无管麻醉。

要点

  • THRIVE使JORRP患儿呼吸暂停时间延长至8.9分钟,较对照组3.8分钟显著增加。
  • THRIVE降低二氧化碳上升速率,2-5岁组和6-12岁组均显著低于对照组。
  • THRIVE期间最低SpO2显著高于对照组,安全性良好。

核心结论

  • THRIVE可安全延长JORRP患儿手术中的呼吸暂停时间,并降低二氧化碳上升速率。

临床怎么用

  • 对于JORRP患儿无管麻醉,可考虑使用THRIVE作为气道管理技术以延长安全呼吸暂停时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence is lacking regarding the efficacy of transnasal humidified rapid insufflation ventilatory exchange (THRIVE) in tubeless anesthesia, especially in pediatric patients. This study aimed to evaluate the use of THRIVE for juvenile onset recurrent respiratory papillomatosis (JORRP) patients. METHODS: Twenty-eight children aged 2 to 12 years with JORRP, abnormal airways, and ASA physical status II-III that presented for surgical treatment under general anesthesia were included in this study. Each patient received 2 interventions in random order, with a 5-minute washout period between treatments: apnea without oxygen supplementation and apnea with THRIVE intervention. The primary outcome apnea time was defined as the duration from withdrawal of intubation to reintubation and resumption of controlled ventilation. The secondary outcomes were the mean transcutaneous carbon dioxide (tc co2 ) increase rate, the minimum pulse oxygen saturation (Sp o2 ) during apnea, and the occurrence of unexpected adverse effects. RESULTS: The median apnea time in the THRIVE period was significantly longer than that in the control period (8.9 [8.6-9.4] vs 3.8 [3.4-4.3] minutes; mean difference [95% confidence interval (CI)], 5.0 [4.4-5.6]; P < .001) for all patients. The rate of CO 2 change in the control period was higher than that in the THRIVE period both for patients aged 2 to 5 years old (6.29 [5.19-7.4] vs 3.22 [2.92-3.76] mm Hg min -1 ; mean difference [95% CI], 3.09 [2.27-3.67]; P < .001) and for patients aged 6 to 12 years old (4.76 [3.7-6.2] vs 3.38 [2.64-4.0] mm Hg min -1 ; mean difference [95% CI], 1.63 [0.75-2.56]; P < .001). The minimum Sp o2 was significantly higher in the THRIVE period than in the control period (mean difference [95% CI], 19.7 [14.8-22.6]; P < .001). CONCLUSIONS: Our findings demonstrate that THRIVE safely increased the apnea time among children with JORRP undergoing surgery and decreased the rate of carbon dioxide increase. THRIVE is clinically recommended as an airway management technique for tubeless anesthesia in apneic children.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Lei G, Wu L, Xi C, et al. Transnasal Humidified Rapid Insufflation Ventilatory Exchange Augments Oxygenation in Children With Juvenile Onset Recurrent Respiratory Papillomatosis During Surgery: A Prospective Randomized Crossover Controlled Trial. Anesth Analg. 2023. PMID: 37590935. doi:10.1213/ANE.0000000000006521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。